Gary C. Evans, Director at NOVAVAX INC (NVAX), sold 30,000 shares at $5.77 ($173K) on 2014-12-12, disclosed to the SEC on 2014-12-16.
Open-market sale of $173k NVAX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| UAMY | BUY | 2024-12-11 | $290K | — | Filing → |
| UAMY | BUY | 2023-01-20 | $10K | — | Filing → |
| UAMY | BUY | 2023-01-17 | $14K | — | Filing → |